Search For Clinical Trials

  • This search contains information about oncology clinical trials at the Curtis and Elizabeth Anderson Cancer Institute at Memorial University Medical Center. This information is primarily for physicians. However, if you are a patient and you have a question about a clinical trial, please feel free to speak with your doctor about it.

    Contact Us
    Department of Clinical Trials — 912-350-8707

    To search for a trial, choose a category from the drop-down menu below. After you have chosen a category, you can also choose a subcategory from the second drop-down menu.


CategorySubcategoryTitleTrial Details
Adjuvant RTOG-0834: Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup TrialTrial Details
Breast NSABP B-49: A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast CancerTrial Details
BreastAdjuvantNSABP B-43: A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma in Situ Resected by Lumpectomy.Trial Details
BreastAdjuvantNSABP B-47: A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women with Node-Positive or High-Risk Node-Negative Her2-Low Invasive Breast CancerTrial Details
BreastAdjuvantRTOG 1005: A Phase III Trial of Accelerated Whole Breast Irradiation with Hypo-fractionation Plus Concurrent Boost versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast CancerTrial Details
BreastAdjuvantSWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or LessTrial Details
BreastAdjuvant/NeoadjuvantNSABP B-51: A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant ChemotherapyTrial Details
BreastNeoadjuvantCALGB 40903: A Phase II Study of Neoadjuvant Letrozole for Postmenopausal Women with Estrogen Receptor Positive Ductal Carcinoma in Situ (DCIS)Trial Details
Cancer Control Alliance A021202: Prospective Randomized Phase II Trial of Pazopanib (NSC # 737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid TumorsTrial Details
Cancer Control EC-FV-06:A Randomized Double-Blind Phase 3 Trial Comparing EC145 and Pegylated Liposomal Doxorubicin (PLD/Doxil®/Caelyx®) in Combination Versus PLD in Participants With Platinum-Resistant Ovarian CancerTrial Details
Cancer Control SWOG S0702: A Prospective Observational Multicenter Cohort Study to Assess the Incidence of Osteonecrosis of the Jaw (ONJ) in Cancer Patients with Bone Metastases Starting on Zoledronic Acid Treatment.Trial Details
Childrens ACCRN07: Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN)Trial Details
Childrens AOST06B1: A COG Study for Collecting and Banking Osteosarcoma SpecimensTrial Details
Childrens Intergroup Trial for Children or Adolescents With B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk PatientsTrial Details
ChildrensALLAALL0434: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaTrial Details
ChildrensALLAALL0631: A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition (CEP-701, Lestaurtinib; IND #76431; NSC# 617807)Trial Details
ChildrensALLAALL07P1: Bortezomib and Combination Chemotherapy in Treating Younger Patients with Recurrent, Refractory, or Secondary Acute Myeloid LeukemiaTrial Details
ChildrensALLAALL08B1: Risk-Based Classification System of Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaTrial Details
ChildrensALLAALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)Trial Details
ChildrensALLAALL1131, A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789) in the Very High Risk Stratum.Trial Details
ChildrensALLABTR01B1: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples from Young Patients with CancerTrial Details
ChildrensAMLAAML08B1: Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)Trial Details
ChildrensAMLAAML1031, A Phase III Randomized Trial for Patients with de novo AML using Bortezomib (IND# 58443) and Sorafenib (IND# 69896) for Patients with High Allelic Ratio FLT3/ITDTrial Details
ChildrensAMLACCL0993: A Randomized Open-Label Trial of Caspofungin versus Fluconazole to Prevent Invasive Fungal Infection in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)Trial Details
ChildrensAMLANHL04B1: Collecting and Storing Tissue Samples from Patients with Rare or Cutaneous Non-Hodgkin LymphomaTrial Details
ChildrensCNSACNS0331: A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized TrialTrial Details
ChildrensCNSACNS0332: Chemotherapy and Radiation Therapy in Treating Young Patients with Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal TurnTrial Details
ChildrensCNSACNS0334: A Phase III Randomized Trial for the Treatment of Newly Diagnosed Supratentorial PNET and High Risk Medulloblastoma in Children < 36 months old with Intensive Induction Chemotherapy with Methotrexate Followed by Consolidation with Stem Cell Rescue Versus the Same Therapy Without MethotrexateTrial Details
ChildrensCNSACNS0821:Temozolomide With Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening TrialTrial Details
ChildrensCNSACNS0822: A Randomized, Phase II/III Study of Vorinotat (IND#71976) and Local Irradiation OR Temozolomide and Local Irradiation OR Bevacizumab (IND#7921) and Local Irradiation Followed by Maintenance Bevacizumab and Temozolomide in Children with Newly Diagnosed High-Grade GliomasTrial Details
ChildrensCNSACNS0831, Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 Years.Trial Details
ChildrensCNSACNS0927: A Phase I/II Study of Suberoylanilide Hydromaxic Acid (SAHA, Vorinostat) and Local Irradiation, Followed by Maintenance SAHA in Children with Newly Diagnosed Diffuse Intrinsic Pontine Gilomas (DIPG)Trial Details
ChildrensCNSACNS1022: A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients With Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway GliomasTrial Details
ChildrensCNSALTE07C1: Neuropsychological and Behavioral Testing in Young Patients with Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)Trial Details
ChildrensEwing SarcomaAEWS07B1: Collecting and Storing Biological Samples From Patients with Ewing SarcomaTrial Details
ChildrensEwing SarcomaAEWS1031: A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing SarcomaTrial Details
ChildrensLiver NeuroblastomaAHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver CancerTrial Details
ChildrensNeuroblastomaANBL0032: Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell RescueTrial Details
ChildrensNeuroblastomaANBL00B1: Biomarkers in Tumor Tissue Samples from Patients with Newly Diagnosed Neuroblastoma or GanglioneuroblastomaTrial Details
ChildrensNeuroblastomaANBL1221: A Phase II Randomized Trial of Irinotecan/Temozolomide With Temsirolimus (NSC# 683864, IND# 61010) or Chimeric 14.18 Antibody (ch14.18) (NSC# 623408, IND# 4308) in Children With Refractory, Relapsed or Progressive NeuroblastomaTrial Details
ChildrensRenalAREN0321: Treatment of High Risk Renal TumorsTrial Details
ChildrensRenalAREN03B2: Study of Kidney Tumors in Young PatientsTrial Details
ChildrensRenalAREN0532: Treatment for Very Low, Low, and Standard Risk Favorable Histology Wilms TumorTrial Details
ChildrensRenalAREN0534: Treatment for Patients with Bilateral, Multicentrick or Bilaterally-Predisposed Unilateral Wilms TumorTrial Details
ChildrensSoft Tissue SarcomaCOG D9902: Collecting and Storing Tissue, Blood, and Bone Marrow Samples from Patients with Rhabdomyosarcoma or Other Soft Tissue Sarcoma Trial Details
Colorectal NSABP MPR-1: NSABP Patient Registry and Biospecimen Profiling RepositoryTrial Details
ColorectalColonAlliance/NCCTG N1048: A Phase II/III Trial of Neoadjuvant FOLFOX, With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal ExcisionTrial Details
ColorectalColonCALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.Trial Details
General Amitriptyline and Topiramate in the Prevention of Childhood MigraineTrial Details
GeneralSickle Cell DiseaseH7T-MC-TADO(b): A Phase 3, Double-Blind, Randomized, Efficacy and Safety Comparison of Prasugrel and Placebo in Pediatric Patients With Sickle Cell Disease.Trial Details
General AdultDeviceAn International Registry of the Wingspan™ Stent System for the Treatment of Intracranial Atherosclerotic Stenosis (IRISSTrial Details
General AdultDeviceNeuroform Stent Proctoring Program for Memorial Health University Medical CenterTrial Details
General AdultDeviceThe Investigational Plan for the Evaluation of the ACADIA™ Facet Replacement System (Pivotal IDE Trial) Protocol #1020-9052Trial Details
Genitourinary Randomized Phase II Study Comparing Cabozantinib (NSC #761968 and IND #116059) With Commercially Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell CarcinomaTrial Details
GenitourinaryUrotheliumCALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell CarcinomaTrial Details
GynecologicCervicalGOG 0244: The Lymphedema and Gynecologic Cancer (Leg) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed PatientsTrial Details
GynecologicCervicalGOG 0263: Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy.Trial Details
GynecologicCervicalGOG-0265: A Phase II Evaluation of ADXS11-001 (NSC 752718, BB-IND#13,712) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the CervixTrial Details
GynecologicCervixGOG 0724: Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy With or Without Adjuvant Chemotherapy in High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy.Trial Details
GynecologicEndometrialGOG 0238: A Randomized Trial of Pelvic Irradiation with or without Concurrent Weekly Cisplatin in Patients with Pelvic-only Recurrence of Carcinoma of the Uterine Corpus.Trial Details
GynecologicEndometrialGOG 0258: A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma.Trial Details
GynecologicGestational Trophoblastic NeoplasiaGOG 0275: A Phase III Randomized Trial of Pulse Actinomycin-D Versus Multi-Day Methotrexate for the Treatment of Low-Risk Gestational Trophoblastic NeoplasiaTrial Details
GynecologicOvarianCAN-004: A Randomized, Double-Blinded, Placebo-Controlled Trial of Cvac as Maintenance Treatment in Patients With EOC in CR Following First-Line ChemotherapyTrial Details
GynecologicOvarianGOG-0264: A Randomized Phase II Trial of Paclitaxel and Carboplatin vs. Bleomycin, Etoposide, and Cisplatin for Newly Diagnosed Advanced State and Recurrent Chemonaive Sex Cord-Stromal Tumors of the OvaryTrial Details
GynecologicOvarianGOG-0268: A Phase II Evaluation of Temsirolimus (CCI-779) (NCI Supplied Agent: NSC# 683864, IND# 61010) in Combination With Carboplatin and Paclitaxel Followed by Temsirolimus (CCI-779) Consolidation as First-Line Therapy in the Treatment of Stage III-IV Clear Cell Carcinoma of the OvaryTrial Details
GynecologicOvarian, Primary Peritoneal, Fallopian TubeGOG 0212: A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103_(IND#70177), Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian or Primary Peritoneal Cancer Who Achieve A Complete Clinical Response to Primary Platinum/Taxane Chemotherapy.Trial Details
GynecologicOvarian, Primary Peritoneal, Fallopian TubeGOG 0213: A Phase III, Randomized, Controlled Clinical Trial of Carboplatin and Paclitaxel Alone or in Combination with Bevacizumab Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Primary Peritoneal and Fallopian Tube Cancer. NCI-SUPPLIED AGENTS: BEVACIZUMAB.Trial Details
GynecologicOvarian, Primary Peritoneal, Fallopian TubeGOG 0225: Can Diet and Exercise Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?Trial Details
GynecologicOvarian, Primary Peritoneal, Fallopian TubeGOG 0273: Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal or Fallopian Tube CancerTrial Details
GynecologicOvarian, Primary Peritoneal, Fallopian TubeGOG 3001: A Phase III Randomized, Double-blind, Placebo-controlled, Multicenter Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube CancerTrial Details
GynecologicOvarian, Primary Peritoneal, Fallopian TubeGOG 3003: A Randomized Double-Blind, Placebo-Controlled Phase II Study of VTX-2337 (IND #78,416) in Combination with Pegylated Liposomal Doxorubicin (PLD) in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CancerTrial Details
GynecologicUterineGOG 0261: A Randomized Phase III Trial of Paclitaxel Plus Carboplatin versus Ifosfamide plus Paclitaxel in Chemotherapy-Naïve Patients with Newly Diagnosed Stage I-IV Persistent or Recurrent Carcinosarcoma (MMT) of the Uterus.Trial Details
GynecologicVulvaGOG 0270: Groningen International Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational StudyTrial Details
Head and NeckMetastaticECOG E1305: A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.Trial Details
Head and NeckSquamous CellRTOG 0920: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer.Trial Details
Lung CCCWFU 99211: Feasibility of Delivering a quitline Based Smoking Cessation Intervention in Lung Cancer Patients Receiving Outpatient Treatment: A Pilot StudyTrial Details
Melanoma Alliance/NCCTG N0879: A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant MelanomaTrial Details
SarcomaInterventionalET743-SAR-3007: A Randomized Controlled Study of Yondelis® (Trabectedin) or Dacarbazine for the Treatment of Advanced Liposarcoma or Leiomyosarcoma Previously Treated with an Anthracycline and IfosfamideTrial Details
ThoracicNon-Small Cell /Advance / Metastatic (stage III/IV) CALGB 30607: Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, State IIIB/IV Non-Small Cell Lung Cancer.Trial Details
ThoracicNon-Small Cell /Advance / Metastatic (stage III/IV) SWOG S0819 - Phase III Intergroup A Randomized, Phase III Study Comparing Carboplatin/PaclitaxelorCarboplatin/Paclitaxel/Bevacizumabwith or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC).Trial Details
ThoracicSmall Cell/LimitedCALGB 30610: Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide. Trial Details
UGI CTSU/ECOG E1609: A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High Dose Interferon a-2b for Resected High-Risk MelanomaTrial Details
UGI SWOG S1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) CancerTrial Details
UGIEsophagusRTOG 1010: A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-Overexpressing Esophageal AdenocarcinomaTrial Details
UGILiverCALGB 80802: A Phase III Randomized Study of Sorafenib plus Doxorubicin Versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC).Trial Details
UGIPancreasRTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.Trial Details